Document is current
Any future updates will be listed below
-
Authors
Costa, Daniela
Lopes, David G.
Cruz, Eduardo B.
Henriques, Ana R.
Branco, Jaime
Canhão, Helena
Rodrigues, Ana M.
-
Funding
Funding for this research was provided by:
Fundação para a Ciência e a Tecnologia (SFRH/BD/148420/2019)
Pfizer (64165707, 64165707)
- License Information
-
More Information
Article History
Received: 12 August 2022
Accepted: 21 June 2023
First Online: 21 July 2023
Declarations
:
: The EpiReumaPt study was approved by the Ethics Committee of NOVA Medical School and the Portuguese Data Protection Authority (<i>Comissão Nacional de Proteção de Dados</i>). This secondary analysis of EpiReumaPt database presented in this study was additionally approved by the Ethics Committee of NOVA Medical School. This study was performed in accordance with the Declaration of Helsinki and revised in 2013 in Fortaleza. Written informed consent was obtained from all participants before entering in EpiReumaPt study, as described elsewhere [CitationRef removed].
: Not Applicable.
: All authors declare no competing interests.
